6:08 PM
 | 
Mar 04, 2008
 |  BC Extra  |  Financial News

Cell Therapeutics sells note deal, submits Xyotax MAA

Cell Therapeutics (NASDAQ:CTIC) raised $51.7 million through the sale of convertible senior notes due 2012 and warrants to purchase 7.3 million shares of common stock. Of the $51.7 million, $16.2 million is being used to make payments...

Read the full 165 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >